Day: May 27, 2020

Tampa, FL, May 27, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Enviro-Serv Inc. (USOTC: EVSV) is extremely excited to announce the company has been issued its Florida FDACS hemp license on May 1st AND will be planting its 2020 hemp crop in Wisconsin within two weeks (weather permitting) and its first ever Florida crop by the end of July.Enviro-Serv, Inc. Chairman and CEO Chris Trina stated, “We are extremely pleased to announce the following update in regards to our Hemp Operations in both Wisconsin and Florida. In Wisconsin we will be planting our first ever 15,000 “CBD” clones of an extremely high quality genetic strain in our newest farming partnership located near Fond du Lac. We will also be planting 10,000 high quality feminized “CBG” seeds purchased from our Oregon genetics distributor used last season. This is double...

BOSTON, May 27, 2020 (GLOBE NEWSWIRE) — Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, is scheduled to participate in a virtual fireside chat at the Jefferies 2020 Healthcare Conference on Wednesday, June 3, 2020, at 3:00 p.m. ET. To access the live webcast presentation, or the subsequent archived recording, please visit the “Investors” section of the Ziopharm website at www.ziopharm.com.About Ziopharm Oncology, Inc. Ziopharm is developing non-viral and cytokine-driven cell and gene therapies that weaponize the body’s immune system to treat the millions of people globally diagnosed with a solid tumor each year. With its multiplatform approach, Ziopharm is at the forefront of immuno-oncology with a goal to treat any type of solid tumor. Ziopharm’s pipeline...

NORDIC ID OYJYHTIÖTIEDOTE 27.5.2020 KELLO 15.10  Nordic ID Oyj:n varsinainen yhtiökokous pidettiin keskiviikkona 27.5.2020 Salossa.Tilinpäätöksen vahvistaminenYhtiökokous vahvisti yhtiön tilinpäätöksen tilikaudelta 2019.Vastuuvapaudesta päättäminenYhtiökokous myönsi vastuuvapauden yhtiön hallitukselle ja toimitusjohtajalle tilikaudelta 1.1.-31.12.2019.OsingonmaksuYhtiökokous päätti hallituksen ehdotuksen mukaisesti, että tilikaudelta 2019 yhtiön voitonjakokelpoisista varoista ei makseta osinkoa.Hallituksen jäsenten palkkiot ja hallituksen kokoonpanoYhtiökokous päätti hallituksen ehdotuksen mukaisesti, että hallituksen puheenjohtajalle maksetaan palkkiona 4.000 euroa kuukaudessa ja hallituksen muille jäsenille kullekin 2.000 euroa kuukaudessa.Hallituksen ehdotuksen mukaisesti yhtiökokous vahvisti hallituksen jäsenten lukumääräksi kuusi....

Topline data on schedule for summer 2020Systemic sclerosis (SSc) is a rare, serious and life-threatening autoimmune disease affecting ~200,000 people in the U.S., EU and JapanThere are no FDA-approved therapies for the overall treatment of SScNorwood, MA, May 27, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that the last subject completed their final visit in the Company’s RESOLVE-1 Phase 3 trial of lenabasum for the treatment of systemic sclerosis. Topline results from the study are on track for summer 2020.“We would like to express our sincere gratitude to our staff, our clinical collaborators and the study participants for their commitment...

Company announcement number 41/2020Result of auction of mortgage covered bonds (SDRO’s) in series 11F, 12F and 12GToday, Realkredit Danmark has completed the auctions of mortgage covered bonds (SDRO’s) in series 11F, 12F and 12G for the refinancing of FlexKort®, RD Cibor6® and RD Euribor3® as of 1 July 2020.The result of the auctions is set out in the appendix to this announcement.The Executive BoardAny additional questions should be addressed to Christian Rosenstand, Head of RD Funding, phone +45 45 13 20 19.AttachmentsNr. 41_Resultat af auktioner over obligationer_ukBilag til selskabsmeddelelse nr. 41-2020_uk

Selskabsmeddelelse nummer 41/2020

MIAMI, May 27, 2020 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ:  OPK) announced today that management will be participating in the Jefferies Virtual Healthcare Conference being held June 2-4, 2020.  Management will be hosting one-on-one meetings with investors via organized conference calls and will be presenting on Wednesday, June 3 at 3:00 p.m. Eastern time.The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website and accessible by clicking here.  About OPKO Health, Inc.OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.Contacts:LHA...